Wnt interaction and extracellular release of prominin-1/CD133 in human malignant melanoma cells

Experimental Cell Research

Volumn 319, Issue 6, 2013, Pages 810-819

  Rappa, Germana ^a   Mercapide, Javier ^a   Anzanello, Fabio ^a   Le, Thuc T ^b   Johlfs, Mary G ^a   Fiscus, Ronald R ^a   Wilsch Bräuninger, Michaela ^c   Corbeil, Denis ^d   Lorico, Aurelio ^a  

^a ROSEMAN UNIVERSITY OF HEALTH SCIENCES   (United States)

^b NEVADA CANCER INSTITUTE   (United States)

^c MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

^d CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

Author keywords

Catenin; Melanoma; Prominin 1; Vesicles; Wnt

Indexed keywords

BETA CATENIN; CD133 ANTIGEN; DYE; FAT DROPLET; LEF PROTEIN; OIL RED O; PROMININ 1; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CELL SIZE; CELL STRUCTURE; CELL VACUOLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GOLGI COMPLEX; HUMAN; HUMAN CELL; INTRACELLULAR MEMBRANE; LIGHT SCATTERING; MELANOMA; MELANOMA CELL; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; RAMAN SPECTROMETRY; SIGNAL TRANSDUCTION; STAINING; TUMOR CELL CULTURE; TUMOR CELL LINE;

EID: 84875232581     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.01.003     Document Type: Article

References (41)

1. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics. CA Cancer J. Clin. 2010, 60:277-300.
2. van Akkooi A.C., de Wilt J.H., Verhoef C., Schmitz P.I., van Geel A.N., Eggermont A.M., Kliffen M. Clinical relevance of melanoma micrometastases (<0.1mm) in sentinel nodes: are these nodes to be considered negative?. Ann. Oncol. 2006, 17:1578-1585.
3. Riker A.I., Enkemann S.A., Fodstad O., Liu S., Ren S., Morris C., Xi Y., Howell P., Metge B., Samant R.S., Shevde L.A., Li W., Eschrich S., Daud A., Ju J., Matta J. The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med. Genomics 2008, 1:13.
4. Monzani E., Facchetti F., Galmozzi E., Corsini E., Benetti A., Cavazzin C., Gritti A., Piccinini A., Porro D., Santinami M., Invernici G., Parati E., Alessandri G., La Porta C.A. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur. J. Cancer 2007, 43:935-946.
5. B.K. Sharma, V. Manglik, E.G. Elias, Immuno-expression of human melanoma stem cell markers in tissues at different stages of the disease, J. Surg. Res. 163 e11-e15.
6. M. Sztiller-Sikorska, K. Koprowska, J. Jakubowska, I. Zalesna, M. Stasiak, M. Duechler, M.E. Czyz, Sphere formation and self-renewal capacity of melanoma cells is affected by the microenvironment, Melanoma Res. 22 215-224.
7. Fusi A., Reichelt U., Busse A., Ochsenreither S., Rietz A., Maisel M., Keilholz U. Expression of the stem cell markers nestin and CD133 on circulating melanoma cells. J. Invest. Dermatol. 2011, 131:487-494.
8. Fodstad O., Kjonniksen I., Aamdal S., Nesland J.M., Boyd M.R., Pihl A. Extrapulmonary, tissue-specific metastasis formation in nude mice injected with FEMX-I human melanoma cells. Cancer Res. 1988, 48:4382-4388.
9. Rappa G., Fodstad O., Lorico A. The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells 2008, 26:3008-3017.
10. Marzesco A.M., Janich P., Wilsch-Brauninger M., Dubreuil V., Langenfeld K., Corbeil D., Huttner W.B. Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells. J. Cell Sci. 2005, 118:2849-2858.
11. Dubreuil V., Marzesco A.M., Corbeil D., Huttner W.B., Wilsch-Brauninger M. Midbody and primary cilium of neural progenitors release extracellular membrane particles enriched in the stem cell marker prominin-1. J. Cell Biol. 2007, 176:483-495.
12. Bauer N., Wilsch-Brauninger M., Karbanova J., Fonseca A.V., Strauss D., Freund D., Thiele C., Huttner W.B., Bornhauser M., Corbeil D. Haematopoietic stem cell differentiation promotes the release of prominin-1/CD133-containing membrane vesicles-a role of the endocytic-exocytic pathway. EMBO Mol. Med. 2011, 3:398-409.
13. Murakami T., Toda S., Fujimoto M., Ohtsuki M., Byers H.R., Etoh T., Nakagawa H. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential. Biochem. Biophys. Res. Commun. 2001, 288:8-15.
14. O.M. Eichhoff, A. Weeraratna, M.C. Zipser, L. Denat, D.S. Widmer, M. Xu, L. Kriegl, T. Kirchner, L. Larue, R. Dummer, K.S. Hoek, Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching, Pigm. Cell Melanoma Res. 24 631-642.
15. Giebel B., Corbeil D., Beckmann J., Hohn J., Freund D., Giesen K., Fischer J., Kogler G., Wernet P. Segregation of lipid raft markers including CD133 in polarized human hematopoietic stem and progenitor cells. Blood 2004, 104:2332-2338.
16. Ge X., Jin Q., Zhang F., Yan T., Zhai Q. PCAF acetylates {beta}-catenin and improves its stability. Mol. Biol. Cell 2009, 20:419-427.
17. Levy L., Wei Y., Labalette C., Wu Y., Renard C.A., Buendia M.A., Neuveut C. Acetylation of beta-catenin by p300 regulates beta-catenin-Tcf4 interaction. Mol. Cell. Biol. 2004, 24:3404-3414.
18. Wolf D., Rodova M., Miska E.A., Calvet J.P., Kouzarides T. Acetylation of beta-catenin by CREB-binding protein (CBP). J. Biol. Chem. 2002, 277:25562-25567.
19. Yang M., Waterman M.L., Brachmann R.K. hADA2a and hADA3 are required for acetylation, transcriptional activity and proliferative effects of beta-catenin. Cancer Biol. Ther. 2008, 7:120-128.
20. Le T.T., Huff T.B., Cheng J.X. Coherent anti-Stokes Raman scattering imaging of lipids in cancer metastasis. BMC Cancer 2009, 9:42.
21. Nan X., Cheng J.X., Xie X.S. Vibrational imaging of lipid droplets in live fibroblast cells with coherent anti-Stokes Raman scattering microscopy. J. Lipid Res. 2003, 44:2202-2208.
22. Yen K., Le T.T., Bansal A., Narasimhan S.D., Cheng J.X., Tissenbaum H.A. A comparative study of fat storage quantitation in nematode Caenorhabditis elegans using label and label-free methods. PLoS One 2010, 5.
23. Yin A.H., Miraglia S., Zanjani E.D., Almeida-Porada G., Ogawa M., Leary A.G., Olweus J., Kearney J., Buck D.W. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997, 90:5002-5012.
24. Corbeil D., Marzesco A.M., Wilsch-Brauninger M., Huttner W.B. The intriguing links between prominin-1 (CD133), cholesterol-based membrane microdomains, remodeling of apical plasma membrane protrusions, extracellular membrane particles, and (neuro)epithelial cell differentiation. FEBS Lett. 2010, 584:1659-1664.
25. Thery C., Zitvogel L., Amigorena S. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2002, 2:569-579.
26. Evans C.L., Xie X.S. Coherent anti-stokes Raman scattering microscopy: chemical imaging for biology and medicine. Annu. Rev. Anal. Chem. (Palo Alto Calif) 2008, 1:883-909.
27. Huttner H.B., Janich P., Kohrmann M., Jaszai J., Siebzehnrubl F., Blumcke I., Suttorp M., Gahr M., Kuhnt D., Nimsky C., Krex D., Schackert G., Lowenbruck K., Reichmann H., Juttler E., Hacke W., Schellinger P.D., Schwab S., Wilsch-Brauninger M., Marzesco A.M., Corbeil D. The stem cell marker prominin-1/CD133 on membrane particles in human cerebrospinal fluid offers novel approaches for studying central nervous system disease. Stem. Cells 2008, 26:698-705.
28. Muralidharan-Chari V., Clancy J.W., Sedgwick A., D'Souza-Schorey C. Microvesicles: mediators of extracellular communication during cancer progression. J. Cell Sci. 2010, 123:1603-1611.
29. Roper K., Corbeil D., Huttner W.B. Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane. Nat. Cell Biol. 2000, 2:582-592.
30. Guo Y., Cordes K.R., Farese R.V., Walther T.C. Lipid droplets at a glance. J. Cell Sci. 2009, 122:749-752.
31. McNeil P.L., Kirchhausen T. An emergency response team for membrane repair. Nat. Rev. Mol. Cell Biol. 2005, 6:499-505.
32. Ghosh P.K., Vasanji A., Murugesan G., Eppell S.J., Graham L.M., Fox P.L. Membrane microviscosity regulates endothelial cell motility. Nat. Cell Biol. 2002, 4:894-900.
33. Taraboletti G., Perin L., Bottazzi B., Mantovani A., Giavazzi R., Salmona M. Membrane fluidity affects tumor-cell motility, invasion and lung-colonizing potential. Int. J. Cancer 1989, 44:707-713.
34. Sherbet G.V. Membrane fluidity and cancer metastasis. Exp. Cell Biol. 1989, 57:198-205.
35. Rubinfeld B., Robbins P., El-Gamil M., Albert I., Porfiri E., Polakis P. Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 1997, 275:1790-1792.
36. Rimm D.L., Caca K., Hu G., Harrison F.B., Fearon E.R. Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma. Am. J. Pathol. 1999, 154:325-329.
37. Weeraratna A.T., Jiang Y., Hostetter G., Rosenblatt K., Duray P., Bittner M., Trent J.M. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 2002, 1:279-288.
38. W.E. Damsky, D.P. Curley, M. Santhanakrishnan, L.E. Rosenbaum, J.T. Platt, B.E. Gould Rothberg, M.M. Taketo, D. Dankort, D.L. Rimm, M. McMahon, M. Bosenberg, beta-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas, Cancer Cell 20 741-754.
39. Horst D., Kriegl L., Engel J., Jung A., Kirchner T. CD133 and nuclear beta-catenin: the marker combination to detect high risk cases of low stage colorectal cancer. Eur. J. Cancer 2009, 45:2034-2040.
40. Boivin D., Labbe D., Fontaine N., Lamy S., Beaulieu E., Gingras D., Beliveau R. The stem cell marker CD133 (prominin-1) is phosphorylated on cytoplasmic tyrosine-828 and tyrosine-852 by Src and Fyn tyrosine kinases. Biochemistry 2009, 48:3998-4007.
41. A.B. Mak, A.M. Nixon, S. Kittanakom, J.M. Stewart, G.I. Chen, J. Curak, A.C. Gingras, R. Mazitschek, B.G. Neel, I. Stagljar, J. Moffat, Regulation of CD133 by HDAC6 promotes beta-catenin signaling to suppress cancer cell differentiation, Cell Rep. 2 951-963.